A consortium of 11 strains representing rare, low-abundance components of the human microbiota has shown to induce IFN-γ-producing CD8 + T cells in a melanoma animal model when combined with an anti-PD1 immune checkpoint inhibitor (Tanoue et al, 2019). This evidence concerns the gene CD8A and melanoma.